Share
Virtual Clinical Trials Market Size, Share, and Analysis, By Study Type (Interventional, Observational, Expanded Access), By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication (CNS, Autoimmune/Inflammation, Cardiovascular Disease, Metabolic/Endocrinology, Infectious Disease, Oncology, Genitourinary, Ophthalmology, Others) and Regional Forecasts, 2022-2032
Virtual Clinical Trials Market size was USD 7.73 billion in 2021 and projected to grow from USD 8.7 billion in 2023 to USD 15.3 billion by 2032, exhibiting a CAGR of 6.4% during the forecast period.
Virtual Clinical Trials are commonly referred as ‘the decentralized trials’. They are a comparatively fresh addition to the health research domain. They control digital technologies and tools to gather information from members distantly or remotely, in their working or natural living surroundings. The key advantages of virtual clinical trials comprise cost efficiencies, enhanced patient engagement, better data capture and authorized research groups.
Virtual Clinical Trials Market is expected to reach USD 15.3 billion, growing at a CAGR of 6.4% during the forecast period owing to the growing penetration of the adoption of virtual clinical trials and rising number of different illnesses and chronic diseases worldwide. Moreover, the rising adoption of improved and modern technologies in clinical research activities is expected to propel the Virtual Clinical Trials Market.
Virtual Clinical Trials Market is classified based on the Study Type into Interventional, Observational, and Expanded Access. The Interventional category held maximum share in 2021. Since the laboratories are becoming more digitalized and as the number of studies to create new drugs for various diseases is growing quickly, the segment is progressing. An interventional study also studies an involvement on the specific population like a future drug under development, a medical device like a vibration vest, an exercise routine, or a treatment. Three crucial phases of interventional testing should be completed before new prospective drugs can show they are both safe and effective.
Virtual Clinical Trials Market is classified based on the Indication into CNS, Autoimmune/Inflammation, Cardiovascular Disease, Metabolic/Endocrinology, Infectious Disease, Oncology, Genitourinary, Ophthalmology, and Others. The Oncology category registered major share of the market in 2021 and is anticipated to lead during the estimated period. Oncology is the key reason for the market growth of the oncology segment. In 53% of cases, cancer treatment was also approved as an extra indication. The quantity of oncology-related clinical research has doubled during the last ten years. Consequently, a surge in oncology clinical trials and cancer incidences is probably the main reason boosting this segment.
Mounting R&D Activities and Supportive Government Initiatives are Expected to Boost the Market Growth
The use of telehealth along with an increase in R&D activities are the main factors propelling the global Virtual Clinical Trials Market. In addition, the market is expected to be driven by technical improvements, agreements among clinical research institutions, pharmaceutical, and biotechnology businesses, as well as favorable government initiatives. The market is also expanding due to factors like the convenience offered in comparison to traditional methods, the incorporation of mobile-based health platforms, and COVID-19 acting as a catalyst for virtual trials.
Benefits and Convenience of Virtual Methods to the Patients are Expected to Boost the Market Growth
An innovative technique of gathering efficacy and safety data from clinical study members uses a virtual approach that enables individuals to take part in the trial from the convenience of their own homes, ensuring that research can continue even when site visits are not feasible. Thanks to remote monitoring and virtual visits of in-person site visits, participants have the choice and peace of mind that they won't be exposed to unnecessary danger. These elements have a significant impact on the market growth.
Stringent Regulations and Data Privacy of Patients May Restrain the Market Growth
One of the key hampering factors for the global virtual clinical trials market is the strict rules and regulations. Another factor is the challenges associated with virtual clinical trials and complexity in virtual clinical trials. Decentralized clinical trials hold multiple challenges; regulatory compliance, data privacy, and standard operating processes. Data privacy of patients is a key concern.
Virtual Clinical Trials Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America held major share of the Virtual Clinical Trials Market in 2022 and is projected to lead over the estimated period. This supported by the increased government assistance, increased acceptance of new technology in clinical research, and increased R&D in this area. Market participants are also increasing adopting digital technologies to satisfy customer needs.
Clinical trial procedures were imposed with stringent regulations due to the COVID-19 pandemic. Clinical trials and research have been considerably impacted globally by the COVID-19 epidemic. A decrease in patient enrolment in clinical trials is one of the observed disruptors, along with operational difficulties brought on by the need to safeguard patient safety and adhere to the social seclusion, quarantine, and other regulations that were essential elements of the public health response to the pandemic.
|
ATTRIBUTE |
DETAILS |
|
Study Period |
2018-2032 |
|
Base Year |
2022 |
|
Forecast Period |
2022-2032 |
|
Historical Period |
2019-2021 |
|
Growth Rate |
CAGR of 6.4% from 2022-2032 |
|
Unit |
Value (USD Billion) |
|
Segmentation |
Main Segments List |
|
Study Type |
|
|
Phase |
|
|
Indication |
|
|
By Region |
|
Virtual Clinical Trials Market size was estimated at USD 7.73 billion in 2021 and is expected to reach USD 15.3 billion in 2032.
Virtual Clinical Trials are commonly referred as ‘the decentralized trials’. They are a comparatively fresh addition to the health research domain. They control digital technologies and tools to gather information from members distantly or remotely, in their working or natural living surroundings.
Interventional and Oncology segments accounted for the largest Virtual Clinical Trials Market share.
Key players: Accenture, Oracle Corporation, J&J Innovative Medicine, IQVIA Holdings Inc., Labcorp Drug Development, ICON Plc, Dassault Systemes SE, Parexel International Corporation, Clario, Medpace Holdings Inc., Medidata, Signant Health, Medable Inc., Clinical Ink, Croprime, and Other Prominent Players are the key players in the Virtual Clinical Trials Market.
Growing adoption of digitalization in healthcare sector and technological improvements for smooth incorporation of virtual clinical trials in healthcare are the factors driving the Virtual Clinical Trials Market.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
